1.) In your trust how many patients in the last 3* months have been treated for NVAF (Non-Valvular Atrial Fibrillation), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
2.) How many patients in the last 3* months have been treated for DVT (Deep Vein Thrombosis), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
Heparin
3.) How many patients in the last 3* months have been treated for PE (Pulmonary Embolism), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
Heparin
4.) How many patients in the last 3* months have been treated for the prevention of recurrent DVT (Deep Vein Thrombosis) or prevention of recurrent PE (Pulmonary Embolism) with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
*Latest 3 months that you have available

Download response Non-Oral Anti Coagulants (NOACs). 300518